Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

712
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
712
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

404
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
404
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

638
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
638
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy01:26

Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy

465
Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
465
Assessment of the Rectum and Anus01:25

Assessment of the Rectum and Anus

978
Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
978
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

564
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
564

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Updates of CSCO guidelines for colorectal cancer version 2026.

Chinese journal of cancer research = Chung-kuo yen cheng yen chiu·2026
Same author

BRAF mutation predicts survival after immunotherapy across multiple cancer types.

Cancer treatment and research communications·2026
Same author

High Sensitivity Sensor Based on Bound State in the Continuum in Detection for Cancer Cells.

IEEE transactions on bio-medical engineering·2025
Same author

AI-Assisted Detection of Early Gastric Cancer via Visualization of Mucosal Acidity Compromise During Endoscopy.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025
Same author

Updates of CSCO guidelines for colorectal cancer version 2025.

Chinese journal of cancer research = Chung-kuo yen cheng yen chiu·2025
Same author

Surufatinib in advanced neuroendocrine tumours: Final overall survival from two randomised, double-blind, placebo-controlled phase 3 studies (SANET-ep and SANET-p).

European journal of cancer (Oxford, England : 1990)·2025

Related Experiment Video

Updated: Jan 1, 2026

Simplified Human Neutrophil Extracellular Traps NETs Isolation and Handling
09:43

Simplified Human Neutrophil Extracellular Traps NETs Isolation and Handling

Published on: April 16, 2015

31.3K

Rectal NETs and rectosigmoid junction NETs may need to be treated differently.

Wen Cai1,2, Weiting Ge2, Hanguang Hu2,3

  • 1Department of Gastroenterology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.

Cancer Medicine
|December 17, 2019
PubMed
Summary

Survival outcomes differ for rectal and rectosigmoid junction neuroendocrine tumors (NETs). Rectal NETs show distinct survival predictors compared to rectosigmoid junction NETs, necessitating precise anatomical definitions in future research.

Keywords:
neuroendocrine tumorsrectosigmoid junctionrectumrisk factors

More Related Videos

Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction
08:26

Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction

Published on: March 24, 2023

1.3K
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

6.3K

Related Experiment Videos

Last Updated: Jan 1, 2026

Simplified Human Neutrophil Extracellular Traps NETs Isolation and Handling
09:43

Simplified Human Neutrophil Extracellular Traps NETs Isolation and Handling

Published on: April 16, 2015

31.3K
Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction
08:26

Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction

Published on: March 24, 2023

1.3K
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

6.3K

Area of Science:

  • Oncology
  • Gastroenterology
  • Epidemiology

Background:

  • Neuroendocrine tumors (NETs) are a heterogeneous group with increasing incidence.
  • Rectal and rectosigmoid junction NETs are often treated similarly despite potential differences.

Purpose of the Study:

  • To investigate and compare the 5-year survival rates of patients with rectal NETs versus rectosigmoid junction NETs.
  • To identify prognostic factors influencing survival and regional lymph node metastasis for each location.

Main Methods:

  • Analysis of 6675 rectal NET and 329 rectosigmoid junction NET cases from the SEER database.
  • Comparative survival analysis using hazard ratios (HR) and logistic regression for metastasis prediction.
  • Evaluation of factors including tumor differentiation, depth of invasion, metastasis, and surgical intervention.

Main Results:

  • A significant difference in 5-year survival was observed between rectal and rectosigmoid junction NETs (HR=0.82, P=0.01).
  • Tumor differentiation, invasion depth, and metastases were key survival predictors for both locations.
  • Rectosigmoid junction NETs showed better male survival (HR=0.69, P<0.01) and no benefit from primary tumor surgery (P=0.56).
  • Predictors for lymph node metastasis varied, with larger tumors and deeper invasion posing higher risks in both sites, particularly for rectosigmoid junction NETs.

Conclusions:

  • Rectal and rectosigmoid junction NETs exhibit distinct survival patterns and risk factors.
  • Clearer anatomical definitions are crucial for future NET research and treatment stratification.
  • Further investigation is needed to elucidate the underlying biological or clinical reasons for these observed differences.